Home LiteratureArticle Details
PMID: 8321192 Published · ppublish English Journal Article

Acquisition of NFKB1-selective DNA binding by substitution of four amino acid residues from NFKB1 into RelA.

Molecular and cellular biology ·Vol. 13 ·No. 7 ·1993-07-00 ·Pages 3850-9

Coleman TA, Kunsch C, Maher M, Ruben SM, Rosen CA

Abstract

The subunits of NF-kappa B, NFKB1 (formerly p50) and RelA (formerly p65), belong to a growing family of transcription factors that share extensive similarity to the c-rel proto-oncogene product. The homology extends over a highly conserved stretch of approximately 300 amino acids termed the Rel homology domain (RHD). This region has been shown to be involved in both multimerization (homo- and heterodimerization) and DNA binding. It is now generally accepted that homodimers of either subunit are capable of binding DNA that contains a kappa B site originally identified in the immunoglobulin enhancer. Recent studies have demonstrated that the individual subunits of the NF-kappa B transcription factor complex can be distinguished by their ability to bind distinct DNA sequence motifs. By using NFKB1 and RelA subunit fusion proteins, different regions within the RHD were found to confer DNA-binding and multimerization functions. A fusion protein that contains 34 N-terminal amino acids of NFKB1 and 264 amino acids of RelA displayed preferential binding to an NFKB1-selective DNA motif while dimerizing with the characteristics of RelA. Within the NFKB1 portion of this fusion protein, a single amino acid change of His to Arg altered the DNA-binding specificity to favor interaction with the RelA-selective DNA motif. Furthermore, substitution of four amino acids from NFKB1 into RelA was able to alter the DNA-binding specificity of the RelA protein to favor interaction with the NFKB1-selective site. Taken together, these findings demonstrate the presence of a distinct subdomain within the RHD involved in conferring the DNA-binding specificity of the Rel family of proteins.

MeSH Terms
Amino Acid Sequence Base Sequence Cell Line Cloning, Molecular DNA/metabolism Humans Molecular Sequence Data Mutagenesis NF-kappa B/chemistry,metabolism Proto-Oncogene Mas Recombinant Fusion Proteins/chemistry,metabolism Transcription Factor RelA
Chemicals
MAS1 protein, human NF-kappa B Proto-Oncogene Mas Recombinant Fusion Proteins Transcription Factor RelA DNA
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Coleman T A
Department of Gene Regulation, Roche Institute of Molecular Biology, Nutley, New Jersey 07110.
Kunsch C
Maher M
Ruben S M
Rosen C A
References (55)
55 references, click to expand
  1. The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression.
    Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1875-9 PMID: 1542686
  2. Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation.
    Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1529-33 PMID: 1542644
  3. Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-kappa B subunit.
    Cell. 1992 Mar 20;68(6):1121-33 PMID: 1547506
  4. I-Rel: a novel rel-related protein that inhibits NF-kappa B transcriptional activity.
    Genes Dev. 1992 May;6(5):745-60 PMID: 1577270
  5. Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro.
    Genes Dev. 1992 May;6(5):761-74 PMID: 1577271
  6. Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B.
    Genes Dev. 1992 May;6(5):775-87 PMID: 1577272
  7. Rapid induction in regenerating liver of RL/IF-1 (an I kappa B that inhibits NF-kappa B, RelB-p50, and c-Rel-p50) and PHF, a novel kappa B site-binding complex.
    Mol Cell Biol. 1992 Jun;12(6):2898-908 PMID: 1588976
  8. Acquisition of myogenic specificity by replacement of three amino acid residues from MyoD into E12.
    Science. 1992 May 15;256(5059):1027-30 PMID: 1317057
  9. The RxxRxRxxC motif conserved in all Rel/kappa B proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein.
    Mol Cell Biol. 1992 Jul;12(7):3094-106 PMID: 1620118
  10. The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50.
    EMBO J. 1992 Aug;11(8):3003-9 PMID: 1639070
  11. Transcription factors: structural families and principles of DNA recognition.
    Annu Rev Biochem. 1992;61:1053-95 PMID: 1497306
  12. Single amino acid substitutions alter helix-loop-helix protein specificity for bases flanking the core CANNTG motif.
    EMBO J. 1992 Nov;11(11):4103-9 PMID: 1327757
  13. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention.
    Genes Dev. 1992 Oct;6(10):1899-913 PMID: 1340770
  14. Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation.
    Mol Cell Biol. 1992 Oct;12(10):4412-21 PMID: 1406630
  15. The precursor of NF-kappa B p50 has I kappa B-like functions.
    Cell. 1992 Oct 16;71(2):243-53 PMID: 1423592
  16. Mutational analysis of the p50 subunit of NF-kappa B and inhibition of NF-kappa B activity by trans-dominant p50 mutants.
    J Virol. 1993 Jan;67(1):288-93 PMID: 8416374
  17. N-terminal DNA-binding domains contribute to differential DNA-binding specificities of NF-kappa B p50 and p65.
    Mol Cell Biol. 1993 Feb;13(2):852-60 PMID: 8423807
  18. Conservation of transcriptional activation functions of the NF-kappa B p50 and p65 subunits in mammalian cells and Saccharomyces cerevisiae.
    Mol Cell Biol. 1993 Mar;13(3):1666-74 PMID: 8441404
  19. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
    Mol Cell Biol. 1982 Sep;2(9):1044-51 PMID: 6960240
  20. Immunoglobulin gene transcription is activated by downstream sequence elements.
    Cell. 1983 Jul;33(3):741-8 PMID: 6409419
  21. Multiple nuclear factors interact with the immunoglobulin enhancer sequences.
    Cell. 1986 Aug 29;46(5):705-16 PMID: 3091258
  22. Dorsal, an embryonic polarity gene in Drosophila, is homologous to the vertebrate proto-oncogene, c-rel.
    Science. 1987 Oct 30;238(4827):692-4 PMID: 3118464
  23. Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro.
    Proc Natl Acad Sci U S A. 1988 Jul;85(13):4700-4 PMID: 3133660
  24. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions.
    Nucleic Acids Res. 1988 Aug 11;16(15):7351-67 PMID: 3045756
  25. I kappa B: a specific inhibitor of the NF-kappa B transcription factor.
    Science. 1988 Oct 28;242(4878):540-6 PMID: 3140380
  26. Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis.
    Proc Natl Acad Sci U S A. 1989 Feb;86(3):821-4 PMID: 2536934
  27. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.
    Cell. 1989 Jul 28;58(2):227-9 PMID: 2665943
  28. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins.
    Science. 1989 Jul 28;245(4916):371-8 PMID: 2667136
  29. In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C.
    Mol Cell Biol. 1989 Jun;9(6):2424-30 PMID: 2548081
  30. Eukaryotic transcriptional regulatory proteins.
    Annu Rev Biochem. 1989;58:799-839 PMID: 2673023
  31. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B.
    Nature. 1990 Apr 12;344(6267):678-82 PMID: 2157987
  32. Purified human I kappa B can rapidly dissociate the complex of the NF-kappa B transcription factor with its cognate DNA.
    Cell. 1990 Apr 20;61(2):255-65 PMID: 2184941
  33. The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product.
    Cell. 1990 Sep 7;62(5):1007-18 PMID: 2203531
  34. Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal.
    Cell. 1990 Sep 7;62(5):1019-29 PMID: 2203532
  35. NF-kappa B, KBF1, dorsal, and related matters.
    Cell. 1990 Sep 7;62(5):841-3 PMID: 2203533
  36. The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain.
    Mol Cell Biol. 1990 Oct;10(10):5473-85 PMID: 2204816
  37. The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function.
    Cell. 1990 Nov 16;63(4):803-14 PMID: 2225078
  38. Cloning of a mitogen-inducible gene encoding a kappa B DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs.
    Nature. 1990 Nov 1;348(6296):76-80 PMID: 2234062
  39. The dorsal morphogen is a sequence-specific DNA-binding protein that interacts with a long-range repression element in Drosophila.
    Cell. 1991 Jan 25;64(2):439-46 PMID: 1988156
  40. DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide.
    Cell. 1991 Mar 8;64(5):961-9 PMID: 2001591
  41. Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B.
    Science. 1991 Mar 22;251(5000):1490-3 PMID: 2006423
  42. The inducible transcription activator NF-kappa B: regulation by distinct protein subunits.
    Biochim Biophys Acta. 1991 Apr 16;1072(1):63-80 PMID: 2018779
  43. Inhibition of transcription factors belonging to the rel/NF-kappa B family by a transdominant negative mutant.
    EMBO J. 1991 Jul;10(7):1827-32 PMID: 1675604
  44. Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity.
    Cell. 1991 Jun 28;65(7):1281-9 PMID: 1829648
  45. The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation.
    Genes Dev. 1991 Aug;5(8):1464-76 PMID: 1907941
  46. Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65.
    Nature. 1991 Aug 22;352(6337):733-6 PMID: 1876189
  47. Rel-associated pp40: an inhibitor of the rel family of transcription factors.
    Science. 1991 Sep 13;253(5025):1268-71 PMID: 1891714
  48. Rapid and efficient purification of native histidine-tagged protein expressed by recombinant vaccinia virus.
    Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8972-6 PMID: 1924358
  49. The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B.
    EMBO J. 1991 Dec;10(12):3805-17 PMID: 1935902
  50. Generation of p50 subunit of NF-kappa B by processing of p105 through an ATP-dependent pathway.
    Nature. 1991 Dec 5;354(6352):395-8 PMID: 1956402
  51. Cytoplasmic retention, DNA binding and processing of the NF-kappa B p50 precursor are controlled by a small region in its C-terminus.
    EMBO J. 1991 Dec;10(13):4159-67 PMID: 1756723
  52. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50.
    Cell. 1991 Dec 20;67(6):1075-87 PMID: 1760839
  53. Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative.
    Mol Cell Biol. 1992 Feb;12(2):444-54 PMID: 1732726
  54. RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.
    Mol Cell Biol. 1992 Feb;12(2):674-84 PMID: 1732739
  55. I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family.
    Cell. 1992 Mar 20;68(6):1109-20 PMID: 1339305
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1993-07-00
Pages
3850-9
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC359913
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]